"(This) suggests an alternative way in which cancer treatments might work in the future if therapies can be targeted at the process of interaction between malignant and healthy cells," said Prof. Roberto Mayor (UCL Cell & Developmental Biology).
Read: Telegraph More: UCL News io9 Science Business
Close
